PPPP 2026 Congress Highlights Critical Role of Early Microbiota Colonization and Long-Term Health Outcomes in Pediatrics
The PPPP 2026 congress, recently concluded in the historic city of Lecce, Italy, has set a new benchmark for the…
The PPPP 2026 congress, recently concluded in the historic city of Lecce, Italy, has set a new benchmark for the…
A groundbreaking, large-scale analysis of nearly 100,000 individuals has revealed a significant association between the use of glucagon-like peptide-1 (GLP-1)…
The medical community has long recognized Polycystic Ovary Syndrome (PCOS) as the leading endocrine disorder among women of reproductive age,…
Polycystic Ovary Syndrome (PCOS), a complex endocrine disorder affecting an estimated 8% to 13% of women of reproductive age worldwide,…
New research indicates that glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications widely prescribed for type 2 diabetes and…
Polycystic Ovary Syndrome (PCOS) remains one of the most prevalent endocrine disorders among women of reproductive age, affecting approximately 8%…
Polycystic Ovary Syndrome (PCOS) remains the most prevalent endocrine disorder among women of reproductive age globally, affecting an estimated 8%…
Polycystic Ovary Syndrome (PCOS) represents one of the most prevalent endocrine disorders among women of reproductive age, affecting between 6%…
New research emerging from a collaborative effort between the University of Eastern Finland, the Karolinska Institutet in Stockholm, and Griffith…
Polycystic Ovary Syndrome (PCOS) remains the leading endocrine disorder among women of reproductive age globally, characterized by a complex interplay…